J&J reaches $6m settlement over counterfeit surgical tools
09-02-2021
Johnson & Johnson unit settles patent dispute over hypertension drug
28-01-2021
Gil C / Shutterstock.com
The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board (PTAB) decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Ethicon, Johnson & Johnson, patent, PTAB, USPTO, US Court of Appeals for the Federal Circuit, medical devices, inter partes review,
